RAISING FUNDS FOR TGEN RESEARCH

Late-stage diagnosis of ovarian cancer and the resulting drug resistance of
such advanced tumors has left the success rate of treatment unchanged in the past 30 years, despite improvements in drug therapies.
 
Dr. Heather Cunliffe, head of the Breast and Ovarian Cancer Research Unit at TGen, endeavors to improve that success rate by understanding why ovarian cancer becomes resistant to therapies while simultaneously developing better drug treatments to address the cancer’s early-stage drug resistance.
 
Funds raised by the Anne Rita Monahan Foundation (ARM) will provide
Dr. Cunliffe, and her team, the financial support needed to fully realize her
study and ultimately save lives through early detection methods and improved drug therapies.

MAKE A DONATION AND HELP FIGHT BACK AGAINST
OVARIAN CANCER.

The Anne Rita Monahan Foundation is a 501(c)(3) tax-exempt charitable organization under IRS code. Our Federal Tax ID number is 11-3821047.

To donate click here:

If you wish to donate by phone call 602-264-5539.

If you wish to donate by mail:
Anne Rita Monahan Foundation
5025 N. Central Ave. Suite 531
Phoenix, AZ 85012-1520